A new vaccine that has been approved by the FDA helps children’s health against six different diseases.
Pharmaceutical company Sanofi announced the vaccine approval in a press release December 26.
Sanofi said the vaccine is called VAXELIS™ and it guards children from diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b.
The vaccine is a three-dose series and meant for children six weeks old through four years old.
Sanofi said along with MSD, they are “working to maximize production of VAXELIS to allow for a sustainable supply to meet anticipated U.S. demand. Commercial supply will not be available in the U.S. prior to 2020.”
